Smart Inhalers Market Projected To Reach USD 53.3 Billion By 2030


 San Francisco, 20 Jan 2023: The Report Smart Inhalers Market Size, Share & Trends Analysis Report By Type (Dry Powdered Inhalers, Metered Dose Inhalers), By Indication (Asthma, COPD), By Distribution Channel, By End-use, By Region, And Segment Forecasts, 2022 - 2030

The global smart inhalers market size is expected to reach USD 53.3 billion by 2030, based on a new report by Grand View Research, Inc., expanding at a CAGR of 19.3% from 2022 to 2030. The rising prevalence of chronic respiratory diseases (CRDs) such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and lung disorders is contributing to the growth of the market. According to the European Respiratory Society Congress, COPD is expected to affect over 480 million people in 2022 across the globe.

COVID-19 has increased the demand for smart inhalers due to the rising penetration of cutting-edge digital devices and solutions for respiratory and pulmonary care. Furthermore, in the post-pandemic era, it is expected that the adoption of smart inhalers will increase as healthcare providers are focusing on connected medical devices to ensure that patients receive better and more enhanced care, regardless of the circumstance.

Furthermore, a growing number of businesses are incorporating digital technologies into their products to improve the efficiency of medication and the management of asthma and COPD. In addition, in April 2022, Aptar Pharma, a key market player, introduced HeroTracker Sense, a novel digital chronic respiratory e-health solution that converts a traditional metered dose inhaler into a smart inhaler. Furthermore, a study of the Adherium Smart inhaler also revealed that smart inhaler users experienced several beneficial medical outcomes, including fewer hospitalizations, improved medication adherence, and a decreased need for doctor visits.

Access Research Report of Smart Inhalers Market @ https://www.grandviewresearch.com/industry-analysis/smart-inhalers-market-report

Smart Inhalers Market Report Highlights

  • Based on type, the metered dose inhalers (MDIs) segment held the largest share of over 60.0% in 2021. MDIs are the most preferred inhalers used to treat CRDs. The dry powdered inhalers (DPIs) segment is expected to register the fastest growth rate of 18.6% over the forecast period owing to the convenience of its mechanism, which makes it easier to use for medicine delivery
  • Based on indication, the COPD segment held the largest share of over 50.0% in 2021 due to the high prevalence of COPD as it affects 200 million people globally. The asthma segment is anticipated to grow at the fastest rate of 18.3% over the forecast period owing to the rising number of hospitalizations for asthma, particularly in young children
  • Based on distribution channel, the hospital pharmacies segment held the largest share of over 40.0% in 2021. The elderly population frequently receives hospital care for CRDs, and they consider purchasing medication from hospital pharmacies. The retail pharmacies segment is anticipated to grow at a rate of 19.2% over the forecast period due to the quick expansion and modernization of the existing pharmacies to increase market penetration
  • Based on end-use, the hospitals segment accounted for the largest share of over 50.0% in 2021 as hospitals are a crucial distribution channel between pharmaceutical companies and patients. The home care settings segment is anticipated to grow at the fastest rate of 20.2% over the forecast period due to the growing preference among older patients, rising costs of healthcare, and the convenience offered by the treatments at home
  • In 2021, North America dominated the market with a share of over 45.0% owing to the rising prevalence of CRDs in the region. In the U.S., more than 25 million people suffer from asthma. Asia Pacific is expected to expand at the fastest rate of 21.2% during the forecast period owing to rising incidence rates of COPD and asthma in developing nations such as China and India

List of Key Players in Smart Inhalers Market

  • H&T Presspart Manufacturing Ltd.
  • Personal Air Quality Systems Private Limited
  • COHERO Health Inc.
  • Cognita Labs
  • Adherium Limited
  • Amiko Digital Health Limited
  • Teva Pharmaceuticals Industries Ltd.
  • Propeller Health
  • Novartis AG
  • Pneuma Respiratory Inc.
  • 3M Health Care Limited
  • AireHealth, Inc.
  • FindAir Sp. z o.o

Access Press Release of Smart Inhalers Market @ https://www.grandviewresearch.com/press-release/global-smart-inhalers-market

 

Comments

Post a Comment

Popular posts from this blog

Asia Pacific PoC Diagnostics Market Growth Opportunities, Industry Analysis And Forecast: Grand View Research Inc.

Image
San Francisco, 18 March 2020 :  The Report   Asia Pacific PoC Diagnostics Market  Analysis And Segment Forecasts To 2020 The Asia Pacific point of care (PoC) diagnostics market is expected to reach USD 5,427.1 million by 2020, according to a new study by Grand View Research, Inc. Growing base of geriatric population and the ability to render immediate results and improve patient care coupled with rising market penetration of PACS (picture archiving and communication systems) and EMR (electronic medical records) are expected to drive demand over the next six years. Skilled staff shortages, especially pertaining to the field of diagnostics are also expected to accelerate the market penetration rates of PoC products, by expediting lab automation processes. Rising demand for home healthcare and other healthcare establishments catering to the elderly population and initiatives undertaken by governments to shorten hospital stays by establishing out-patient care models are also expect
Read more

Food Additives Market Size & Share Hit USD 55.53 Billion By 2022 : Grand View Research Inc.

Image
San Francisco, 17 October 2019:   The Report   Global Food Additives Market   Analysis By Product Flavors & Enhancers (Natural, Artificial), Sweeteners (High Intensity, HFCS), Enzymes, Emulsifiers (Mono, Di-Glycerides, Lecithin, Stearoyl Lactylates, Sorbitan Esters), Shelf-life Stabilizers, Fat Replacers (Protein, Starch)] And Segment Forecast To 2022 Global food additives market is expected to reach USD 55.53 billion by 2022, according to a new study by Grand View Research, Inc. Food & beverage industry growth in BRICS and Middle East on account of rising domestic consumption and increasing foreign direct investments is expected to augment market growth. Asia Pacific is expected to be one of the most promising markets on account of growing domestic consumption in China and India owing to population growth and new product launches by food & beverage manufacturers. Availability of raw materials such as sorbitol and lactic acid in China, Indonesia, and Malaysia in light o
Read more

Integration Platform as a Service Market Valuation Is Expected To Exceed USD 2.70 Billion By 2025: Grand View Research Inc.

Image
San Francisco, 18 March 2020 :  The Report   Integration Platform as a Service (IPaaS) Market  Analysis By Integration Type (API, Process, Application, Data), By Services, By Deployment (Cloud, On-Premise, Hybrid) By Region, And Segment Forecasts, 2018 – 2025 The global integration platform as a service (IPaaS) market is expected to reach USD 2.705.8 million by 2025, according to a new report by Grand View Research, Inc. Rising need of advanced systems to improve the process of deploying, developing, and managing enterprise applications globally has been a major factor driving market growth. In addition, recent developments in big data, cloud computing, and Internet of Things (IoT) within organizations’ processes also paved the way for greater development of IPaaS solutions. Integration Platform as a Service is an emerging technology where in the applications, process, data, and application programs are integrated. The integration enables enterprises to reduce the complexity
Read more